Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

The last decade has seen a renewed interested in a risk-adapted approach to the
management of differentiated thyroid cancer (DTC), in which specific treatment and follow …

BTA_Guidelines_for_the_Management_of_Thyroid Cancer_E Page 1 CLINICAL
ENDOCRINOLOGY VOLUME 81 SUPPLEMENT 1 JULY 2014 THE CLINICAL JOURNAL OF …

Background Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Methods Six scientific Italian societies entitled to …

Context: Although response to therapy assessment is a validated tool for dynamic risk
stratification in patients with differentiated thyroid cancer (DTC) treated with total …

The lack of prospective randomized clinical trials for most management topics in
differentiated thyroid cancer forces us to make management recommendations based on …

Background: The utility of serum thyroglobulin (Tg) measurement following partial
thyroidectomy or total/near-total thyroidectomy without radioactive iodine (RAI) for …

Background: Low-risk patients with differentiated thyroid cancer can be treated with thyroid
lobectomy. Serial measurements of serum thyroglobulin (Tg) are recommended for …

Background: The extent of thyroidectomy for low-risk well-differentiated thyroid cancer
(WDTC) remains controversial. Historically, total thyroidectomy (TT) has been recommended …

Introduction: In the past, total thyroidectomy was usually recommended as the initial
therapeutic approach in all but the lowest risk differentiated thyroid cancers. Today, many …